PROFILES - Connect with RTRN Researchers

Karam F. Soliman
Title Associate Dean for Research & Graduate Studies
Faculty Rank Distinguished Professor
Degree Ph.D.
Institution Florida A&M University
Department Basic Pharmaceutical Sciences
Clusters Neurological Disorders and Mental Health
Address
Florida A&M University
College of Pharmacy & Pharmaceutical Scie
1520 ML King Jr Blvd
City Tallahasee
State FL
Postal Code 32307
Telephone (850) 599-3306
Fax 850 599 3667
Email
QR Barcode

Narrative icon

 
Not Available

Programs, Membership, and Biomedical Research icon

RTRN Member - Steering Committee

Publications icon

  Check NIH Public Access Policy Compliance

Loading
Please wait
1. Mazzio EA, Lewis CA, Soliman KFA. Transcriptomic Profiling of MDA-MB-231 Cells Exposed to Boswellia Serrata and 3-O-Acetyl-B-Boswellic Acid; ER/UPR Mediated Programmed Cell Death. Cancer Genomics Proteomics. 2017 Nov-Dec; 14(6):409-425.
2. Messeha SS, Zarmouh NO, Mendonca P, Kolta MG, Soliman KFA. The attenuating effects of plumbagin on pro-inflammatory cytokine expression in LPS-activated BV-2 microglial cells. J Neuroimmunol. 2017 Dec 15; 313:129-137.
3. Bauer D, Redmon N, Mazzio E, Soliman KF. Apigenin inhibits TNFa/IL-1a-induced CCL2 release through IKBK-epsilon signaling in MDA-MB-231 human breast cancer cells. PLoS One. 2017; 12(4):e0175558.
4. Mack N, Mazzio EA, Bauer D, Flores-Rozas H, Soliman KF. Stable shRNA Silencing of Lactate Dehydrogenase A (LDHA) in Human MDA-MB-231 Breast Cancer Cells Fails to Alter Lactic Acid Production, Glycolytic Activity, ATP or Survival. Anticancer Res. 2017 03; 37(3):1205-1212.
5. Mendonca P, Taka E, Bauer D, Cobourne-Duval M, Soliman KF. The attenuating effects of 1,2,3,4,6 penta-O-galloyl-ß-d-glucose on inflammatory cytokines release from activated BV-2 microglial cells. J Neuroimmunol. 2017 Apr 15; 305:9-15.
6. Zarmouh NO, Eyunni SK, Soliman KF. The Benzopyrone Biochanin-A as a reversible, competitive, and selective monoamine oxidase B inhibitor. BMC Complement Altern Med. 2017 Jan 10; 17(1):34.
7. Mazzio EA, Soliman KF. HTP Nutraceutical Screening for Histone Deacetylase Inhibitors and Effects of HDACis on Tumor-suppressing miRNAs by Trichostatin A and Grapeseed (Vitis vinifera) in HeLa cells. Cancer Genomics Proteomics. 2017 01 02; 14(1):17-33.
8. Mazzio EA, Bauer D, Mendonca P, Taka E, Soliman KF. Natural product HTP screening for attenuation of cytokine-induced neutrophil chemo attractants (CINCs) and NO2- in LPS/IFN? activated glioma cells. J Neuroimmunol. 2017 Jan 15; 302:10-19.
9. Mazzio EA, Li N, Bauer D, Mendonca P, Taka E, Darb M, Thomas L, Williams H, Soliman KF. Natural product HTP screening for antibacterial (E.coli 0157:H7) and anti-inflammatory agents in (LPS from E. coli O111:B4) activated macrophages and microglial cells; focus on sepsis. BMC Complement Altern Med. 2016 Nov 15; 16(1):467.
10. Gangapuram M, Jean R, Mazzio E, Badisa R, Eyunni S, Goodman CB, Redda KK, Soliman KF. Substituted Tetrahydroisoquinolines as Microtubule-destabilizing Agents in Triple Negative Human Breast Cancer Cells. Anticancer Res. 2016 10; 36(10):5043-5052.
11. Cobourne-Duval MK, Taka E, Mendonca P, Bauer D, Soliman KF. The Antioxidant Effects of Thymoquinone in Activated BV-2 Murine Microglial Cells. Neurochem Res. 2016 Dec; 41(12):3227-3238.
12. Ramsubhag RR, Massaro CL, Dadich CM, Janeczek AJ, Hoang TT, Mazzio EA, Eyunni S, Soliman KF, Dudley GB. Synthesis of "neoprofen", a rigidified analogue of ibuprofen, exemplifying synthetic methodology for altering the 3-D topology of pharmaceutical substances. Org Biomol Chem. 2016 Aug 16; 14(33):7855-8.
13. Zarmouh NO, Messeha SS, Elshami FM, Soliman KF. Natural Products Screening for the Identification of Selective Monoamine Oxidase-B Inhibitors. European J Med Plants. 2016 May; 15(1).
14. Mochona B, Qi X, Euynni S, Sikazwi D, Mateeva N, Soliman KF. Design and evaluation of novel oxadiazole derivatives as potential prostate cancer agents. Bioorg Med Chem Lett. 2016 06 15; 26(12):2847-2851.
15. Zarmouh NO, Messeha SS, Elshami FM, Soliman KF. Evaluation of the Isoflavone Genistein as Reversible Human Monoamine Oxidase-A and -B Inhibitor. Evid Based Complement Alternat Med. 2016; 2016:1423052.
16. Messeha SS, Zarmouh NO, Taka E, Gendy SG, Shokry GR, Kolta MG, Soliman KF. The Role of Monocarboxylate Transporters and Their Chaperone CD147 in Lactate Efflux Inhibition and the Anticancer Effects of Terminalia chebula in Neuroblastoma Cell Line N2-A. European J Med Plants. 2016; 12(4).
17. Zarmouh NO, Mazzio EA, Elshami FM, Messeha SS, Eyunni SV, Soliman KF. Evaluation of the Inhibitory Effects of Bavachinin and Bavachin on Human Monoamine Oxidases A and B. Evid Based Complement Alternat Med. 2015; 2015:852194.
18. Taka E, Mazzio EA, Goodman CB, Redmon N, Flores-Rozas H, Reams R, Darling-Reed S, Soliman KF. Anti-inflammatory effects of thymoquinone in activated BV-2 microglial cells. J Neuroimmunol. 2015 Sep 15; 286:5-12.
19. Bauer D, Redmon N, Mazzio E, Taka E, Reuben JS, Day A, Sadrud-Din S, Flores-Rozas H, Soliman KF, Darling-Reed S. Diallyl disulfide inhibits TNFa induced CCL2 release through MAPK/ERK and NF-Kappa-B signaling. Cytokine. 2015 Sep; 75(1):117-26.
20. Mazzio E, Georges B, McTier O, Soliman KF. Neurotrophic Effects of Mu Bie Zi (Momordica cochinchinensis) Seed Elucidated by High-Throughput Screening of Natural Products for NGF Mimetic Effects in PC-12 Cells. Neurochem Res. 2015 Oct; 40(10):2102-12.
21. Mateeva N, Gangapuram M, Mazzio E, Eyunni S, Soliman KF, Redda KK. Biological evaluation of synthetic chalcone and flavone derivatives as anti-inflammatory agents. Med Chem Res. 2015 Apr; 24(4):1672-1680.
22. Deiab S, Mazzio E, Eyunni S, McTier O, Mateeva N, Elshami F, Soliman KF. 1,2,3,4,6-Penta-O-galloylglucose within Galla Chinensis Inhibits Human LDH-A and Attenuates Cell Proliferation in MDA-MB-231 Breast Cancer Cells. Evid Based Complement Alternat Med. 2015; 2015:276946.
23. Elhag R, Mazzio EA, Soliman KF. The effect of silibinin in enhancing toxicity of temozolomide and etoposide in p53 and PTEN-mutated resistant glioma cell lines. Anticancer Res. 2015 Mar; 35(3):1263-9.
24. Reams RR, Jones-Triche J, Chan OT, Hernandez BY, Soliman KF, Yates C. Immunohistological analysis of ABCD3 expression in Caucasian and African American prostate tumors. Biomed Res Int. 2015; 2015:132981.
25. Badisa RB, Mina DA, Latinwo LM, Soliman KF. Selective anticancer activity of neurotoxin 1-methyl-4-phenylpyridinium on non-small cell lung adenocarcinoma A549 cells. Anticancer Res. 2014 Oct; 34(10):5447-52.
26. Green JE, Cooperwood JS, Taka E, Soliman KF, Goodman CB, Reams RR. Comparative proteomic analysis reveals growth inhibition by 3-N-alkyloxyestradiol derivative (SERM) in prostate cancer cells. Cancer Genomics Proteomics. 2014 Jul-Aug; 11(4):195-200.
27. Bauer D, Mazzio E, Soliman KF, Taka E, Oriaku E, Womble T, Darling-Reed S. Diallyl disulfide inhibits TNFa-induced CCL2 release by MDA-MB-231 cells. Anticancer Res. 2014 Jun; 34(6):2763-70.
28. Mazzio EA, Soliman KF. Epigenetics and nutritional environmental signals. Integr Comp Biol. 2014 Jul; 54(1):21-30.
29. Gangapuram M, Mazzio E, Eyunni S, Soliman KF, Redda KK. Synthesis and biological evaluation of substituted N-[3-(1H-pyrrol-1-yl)methyl]-1,2,5,6-tetrahydropyridin-1-yl]benzamide/benzene sulfonamides as anti-inflammatory agents. Arch Pharm (Weinheim). 2014 May; 347(5):360-9.
30. Mazzio E, Badisa R, Mack N, Deiab S, Soliman KF. High throughput screening of natural products for anti-mitotic effects in MDA-MB-231 human breast carcinoma cells. Phytother Res. 2014 Jun; 28(6):856-67.
31. Stephenson AP, Schneider JA, Nelson BC, Atha DH, Jain A, Soliman KF, Aschner M, Mazzio E, Renee Reams R. Manganese-induced oxidative DNA damage in neuronal SH-SY5Y cells: attenuation of thymine base lesions by glutathione and N-acetylcysteine. Toxicol Lett. 2013 Apr 26; 218(3):299-307.
32. Deiab S, Mazzio E, Messeha S, Mack N, Soliman KF. High-Throughput Screening to Identify Plant Derived Human LDH-A Inhibitors. European J Med Plants. 2013; 3(4):603-615.
33. Mazzio E, Deiab S, Park K, Soliman KF. High throughput screening to identify natural human monoamine oxidase B inhibitors. Phytother Res. 2013 Jun; 27(6):818-28.
34. Mazzio E, Soliman KF. Whole genome expression profile in neuroblastoma cells exposed to 1-methyl-4-phenylpyridine. Neurotoxicology. 2012 Oct; 33(5):1156-69.
35. Hardaway CM, Badisa RB, Soliman KF. Effect of ascorbic acid and hydrogen peroxide on mouse neuroblastoma cells. Mol Med Rep. 2012 Jun; 5(6):1449-52.
36. Mazzio EA, Boukli N, Rivera N, Soliman KF. Pericellular pH homeostasis is a primary function of the Warburg effect: inversion of metabolic systems to control lactate steady state in tumor cells. Cancer Sci. 2012 Mar; 103(3):422-32.
37. Mazzio EA, Soliman KF. Basic concepts of epigenetics: impact of environmental signals on gene expression. Epigenetics. 2012 Feb; 7(2):119-30.
38. Taka E, Mazzio E, Soliman KF, Renee Reams R. Microarray genomic profile of mitochondrial and oxidant response in manganese chloride treated PC12 cells. Neurotoxicology. 2012 Mar; 33(2):162-8.
39. Reams RR, Kalari KR, Wang H, Odedina FT, Soliman KF, Yates C. Detecting gene-gene interactions in prostate disease in African American men. Infect Agent Cancer. 2011 Sep 23; 6 Suppl 2:S1.
40. Mazzio EA, Close F, Soliman KF. The biochemical and cellular basis for nutraceutical strategies to attenuate neurodegeneration in Parkinson's disease. Int J Mol Sci. 2011 Jan 17; 12(1):506-69.
41. Mazzio EA, Soliman KF. In vitro screening of tumoricidal properties of international medicinal herbs: part II. Phytother Res. 2010 Dec; 24(12):1813-24.
42. Badisa RB, Darling-Reed SF, Soliman KF. The protective role of D-glucose against 1-methyl-4-phenylpyridinium ion (MPP+): induced mitochondrial dysfunction in C6 astroglial cells. Neurochem Res. 2010 Sep; 35(9):1413-21.
43. Mazzio EA, Soliman YI, Soliman KF. Variable toxicological response to the loss of OXPHOS through 1-methyl-4-phenylpyridinium-induced mitochondrial damage and anoxia in diverse neural immortal cell lines. Cell Biol Toxicol. 2010 Dec; 26(6):527-39.
44. Mazzio EA, Smith B, Soliman KF. Evaluation of endogenous acidic metabolic products associated with carbohydrate metabolism in tumor cells. Cell Biol Toxicol. 2010 Jun; 26(3):177-88.
45. Becker A, Soliman KF. The role of intracellular glutathione in inorganic mercury-induced toxicity in neuroblastoma cells. Neurochem Res. 2009 Sep; 34(9):1677-84.
46. Mazzio EA, Soliman KF. In vitro screening for the tumoricidal properties of international medicinal herbs. Phytother Res. 2009 Mar; 23(3):385-98.
47. Reams RR, Agrawal D, Davis MB, Yoder S, Odedina FT, Kumar N, Higginbotham JM, Akinremi T, Suther S, Soliman KF. Microarray comparison of prostate tumor gene expression in African-American and Caucasian American males: a pilot project study. Infect Agent Cancer. 2009 Feb 10; 4 Suppl 1:S3.
48. Soliman Y, Jackson T, Mazzio E, Soliman KF. The effects of piroxicam in the attenuation of MPP+/MPTP toxicity in vitro and in vivo. Neurochem Res. 2009 Feb; 34(2):304-10.
49. Williams ZR, Goodman CB, Soliman KF. Anaerobic glycolysis protection against 1-methy-4-phenylpyridinium (MPP+) toxicity in C6 glioma cells. Neurochem Res. 2007 Jun; 32(6):1071-80.
50. Lee E, Williams Z, Goodman CB, Oriaku ET, Harris C, Thomas M, Soliman KF. Effects of NMDA receptor inhibition by phencyclidine on the neuronal differentiation of PC12 cells. Neurotoxicology. 2006 Jul; 27(4):558-66.
51. Shepherd KR, Lee ES, Schmued L, Jiao Y, Ali SF, Oriaku ET, Lamango NS, Soliman KF, Charlton CG. The potentiating effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on paraquat-induced neurochemical and behavioral changes in mice. Pharmacol Biochem Behav. 2006 Mar; 83(3):349-59.
52. Lee ES, Chen H, Charlton CG, Soliman KF. The role of phospholipid methylation in 1-methyl-4-phenyl-pyridinium ion (MPP+)-induced neurotoxicity in PC12 cells. Neurotoxicology. 2005 Dec; 26(6):945-57.
53. Lee ES, Chen H, Soliman KF, Charlton CG. Effects of homocysteine on the dopaminergic system and behavior in rodents. Neurotoxicology. 2005 Jun; 26(3):361-71.
54. Lee ES, Soliman KF, Charlton CG. Lysophosphatidylcholine decreases locomotor activities and dopamine turnover rate in rats. Neurotoxicology. 2005 Jan; 26(1):27-38.
55. Mazzio EA, Kolta MG, Reams RR, Soliman KF. Inhibitory effects of cigarette smoke on glial inducible nitric oxide synthase and lack of protective properties against oxidative neurotoxins in vitro. Neurotoxicology. 2005 Jan; 26(1):49-62.
56. Elsisi NS, Darling-Reed S, Lee EY, Oriaku ET, Soliman KF. Ibuprofen and apigenin induce apoptosis and cell cycle arrest in activated microglia. Neurosci Lett. 2005 Feb 28; 375(2):91-6.
57. Lee ES, Chen H, Shepherd KR, Lamango NS, Soliman KF, Charlton CG. Inhibitory effects of lysophosphatidylcholine on the dopaminergic system. Neurochem Res. 2004 Jul; 29(7):1333-42.
58. Mazzio EA, Reams RR, Soliman KF. The role of oxidative stress, impaired glycolysis and mitochondrial respiratory redox failure in the cytotoxic effects of 6-hydroxydopamine in vitro. Brain Res. 2004 Apr 09; 1004(1-2):29-44.
59. Mazzio EA, Soliman KF. Effects of enhancing mitochondrial oxidative phosphorylation with reducing equivalents and ubiquinone on 1-methyl-4-phenylpyridinium toxicity and complex I-IV damage in neuroblastoma cells. Biochem Pharmacol. 2004 Mar 15; 67(6):1167-84.
60. Mazzio EA, Soliman KF. Glioma cell antioxidant capacity relative to reactive oxygen species produced by dopamine. J Appl Toxicol. 2004 Mar-Apr; 24(2):99-106.
61. Lee ES, Chen H, Shepherd KR, Lamango NS, Soliman KF, Charlton CG. The inhibitory role of methylation on the binding characteristics of dopamine receptors and transporter. Neurosci Res. 2004 Mar; 48(3):335-44.
62. Mazzio E, Yoon KJ, Soliman KF. Acetyl-L-carnitine cytoprotection against 1-methyl-4-phenylpyridinium toxicity in neuroblastoma cells. Biochem Pharmacol. 2003 Jul 15; 66(2):297-306.
63. Mazzio E, Becker A, Soliman KF. Inflammation and inducible nitric oxide synthase have no effect on monoamine oxidase activity in glioma cells. Biochem Pharmacol. 2003 May 15; 65(10):1719-27.
64. Mazzio EA, Soliman KF. Cytoprotection of pyruvic acid and reduced beta-nicotinamide adenine dinucleotide against hydrogen peroxide toxicity in neuroblastoma cells. Neurochem Res. 2003 May; 28(5):733-41.
65. Sircar R, Soliman KF. Effects of postnatal PCP treatment on locomotor behavior and striatal D2 receptor. Pharmacol Biochem Behav. 2003 Mar; 74(4):943-52.
66. Mazzio E, Soliman KF. D-(+)-glucose rescue against 1-methyl-4-phenylpyridinium toxicity through anaerobic glycolysis in neuroblastoma cells. Brain Res. 2003 Feb 07; 962(1-2):48-60.
67. Mazzio E, Soliman KF. Pyruvic acid cytoprotection against 1-methyl-4-phenylpyridinium, 6-hydroxydopamine and hydrogen peroxide toxicities in vitro. Neurosci Lett. 2003 Feb 06; 337(2):77-80.
68. Mazzio E, Soliman KF. The role of glycolysis and gluconeogenesis in the cytoprotection of neuroblastoma cells against 1-methyl 4-phenylpyridinium ion toxicity. Neurotoxicology. 2003 Jan; 24(1):137-47.
69. Rutledge LP, Ngong JM, Kuperberg JM, Samaan SS, Soliman KF, Kolta MG. Dopaminergic system modulation of nociceptive response in long-term diabetic rats. Pharmacol Biochem Behav. 2002 Dec; 74(1):1-9.
70. Soliman MK, Mazzio E, Soliman KF. Levodopa modulating effects of inducible nitric oxide synthase and reactive oxygen species in glioma cells. Life Sci. 2002 Nov 29; 72(2):185-98.
71. Mazzio E, Becker A, Soliman KF. Characterization of neurotransmitters and dopamine attenuation of inducible nitric oxide synthase in glioma cells. J Neuroimmunol. 2002 Oct; 131(1-2):70-82.
72. Zhao WQ, Williams Z, Shepherd KR, Reuben JS, Lee ES, Darling-Reed S, Lamango N, Soliman KF, Charlton CG. S-adenosyl-methionine-induced apoptosis in PC12 cells. J Neurosci Res. 2002 Aug 15; 69(4):519-29.
73. Yoon K, Soliman K, Redda K. Inhibitory effects of N-(substituted benzoylamino)-4-ethyl-1,2,3,6-tetrahydropyridines on nitric oxide generation in stimulated raw 264.7 macrophages. Drugs Exp Clin Res. 2002; 28(2-3):83-90.
74. Park K, Vora U, Darling SF, Kolta MG, Soliman KF. The role of inducible nitric oxide synthase in cocaine-induced locomotor sensitization. Physiol Behav. 2001 Nov-Dec; 74(4-5):441-7.
75. Huber JD, Darling SF, Park KK, Soliman KF. The role of NMDA receptors in neonatal cocaine-induced neurotoxicity. Pharmacol Biochem Behav. 2001 Jul-Aug; 69(3-4):451-9.
76. Mazzio E, Huber J, Darling S, Harris N, Soliman KF. Effect of antioxidants on L-glutamate and N-methyl-4-phenylpyridinium ion induced-neurotoxicity in PC12 cells. Neurotoxicology. 2001 Apr; 22(2):283-8.
77. Park KK, Reuben JS, Soliman KF. The role of inducible-nitric oxide in cocaine-induced kindling. Exp Biol Med (Maywood). 2001 Mar; 226(3):185-90.
78. Huber J, Darling S, Park K, Soliman KF. Altered responsiveness to stress and NMDA following prenatal exposure to cocaine. Physiol Behav. 2001 Jan; 72(1-2):181-8.
79. Soliman KF. Polyphenols, flavonoids, food constituents and oils attenuate neurodegenerative process. Ethn Dis. 2001; 11(1):165-6.
80. Kuperberg JM, Soliman KF, Stino FK, Kolta MG. Effects of time of day on chlorpyrifos-induced alterations in body temperature. Life Sci. 2000 Sep 08; 67(16):2001-9.
81. Park K, Huber J, Kolta MG, Stino FK, Samaan SS, Soliman KF. Behavioral responses to repeated cocaine exposure in mice selectively bred for differential sensitivity to pentobarbital. Ann N Y Acad Sci. 2000 Sep; 914:323-35.
82. Hill D, Ikaiddi M, Mazzio E, Soliman KF. The neurochemical basis for the behavioral effects of triadimefon. Ann N Y Acad Sci. 2000 Sep; 914:336-53.
83. Heyliger SO, Mazzio EA, Soliman KF. The anti-inflammatory effects of quinolinic acid in the rat. Life Sci. 1999; 64(14):1177-87.
84. Heyliger SO, Goodman CB, Ngong JM, Soliman KF. The analgesic effects of tryptophan and its metabolites in the rat. Pharmacol Res. 1998 Oct; 38(4):243-50.
85. Mazzio EA, Harris N, Soliman KF. Food constituents attenuate monoamine oxidase activity and peroxide levels in C6 astrocyte cells. Planta Med. 1998 Oct; 64(7):603-6.
86. Soliman KF, Mazzio EA. In vitro attenuation of nitric oxide production in C6 astrocyte cell culture by various dietary compounds. Proc Soc Exp Biol Med. 1998 Sep; 218(4):390-7.
87. Choi SJ, Mazzio E, Kolta MG, Soliman KF. Prenatal cocaine exposure affects postnatal dopaminergic systems in various regions of the rat brain. Ann N Y Acad Sci. 1998 May 30; 844:293-302.
88. Choi SJ, Mazzio E, Soliman KF. The effects of gestational cocaine exposure on pregnancy outcome, postnatal development, cognition and locomotion in rats. Ann N Y Acad Sci. 1998 May 30; 844:324-35.
89. Choi SJ, Mazzio EA, Reams RR, Soliman KF. Gestational cocaine exposure alters postnatal pituitary-adrenal axis activity and stress endurance in rats. Ann N Y Acad Sci. 1998 May 30; 844:336-45.
90. Clay LH, Mazzio EA, Kolta MG, Soliman KF. Repeated administration of cocaine alters dopamine uptake and release in the striatum nucleus accumbens. Ann N Y Acad Sci. 1998 May 30; 844:346-55.
91. Choi SJ, Mazzio E, Kolta MG, Soliman KFA. Prenatal Cocaine Exposure Affects Postnatal Dopaminergic Systems in Various Regions of the Rat Braina. Ann N Y Acad Sci. 1998 May; 844(1):293-302.
92. Choi SJ, Mazzio E, Soliman KFA. The Effects of Gestational Cocaine Exposure on Pregnancy Outcome, Postnatal Development, Cognition and Locomotion in Ratsa. Ann N Y Acad Sci. 1998 May; 844(1):324-335.
93. Choi SJ, Mazzio EA, Reams RR, Soliman KFA. Gestational Cocaine Exposure Alters Postnatal Pituitary-Adrenal Axis Activity and Stress Endurance in Ratsa. Ann N Y Acad Sci. 1998 May; 844(1):336-345.
94. Clay LH, Mazzio EA, Kolta MG, Soliman KFA. Repeated Administration of Cocaine Alters Dopamine Uptake and Release in the Striatum Nucleus Accumbensa. Ann N Y Acad Sci. 1998 May; 844(1):346-355.
95. Stino FK, Samaan SS, Kolta MG, Mizinga KM, Soliman KF. Divergent selection for pentobarbital-induced sedation times in mice. Pharmacology. 1998 Feb; 56(2):92-100.
96. Choi SJ, Yoon KJ, Park KK, Ngong JM, Soliman KF. The thymolytic effect of cocaine and monoaminergic drugs in the mouse. Life Sci. 1998; 62(10):905-12.
97. Udoye MO, Nonavinakere VK, Soliman KF. In vivo response of the normal and regenerating adrenal glands to thyroid manipulation in rats. Res Commun Mol Pathol Pharmacol. 1997 Feb; 95(2):221-4.
98. Soliman KF, Reams RR, Udoye MO, Nonavinakere VK. Inhibition of the rat adrenal ornithine decarboxylase activity by immobilization stress and/or dexamethasone. Life Sci. 1997; 60(26):2383-7.
99. Rasekh HR, Davis MD, Cooke LW, Mazzio EA, Reams RR, Soliman KF. The effect of selenium on the central dopaminergic system: a microdialysis study. Life Sci. 1997; 61(11):1029-35.
100. Ikaiddi MU, Akunne HC, Soliman KF. Behavioral and neurochemical effects of acute and repeated administration of triadimefon in the male rat. Neurotoxicology. 1997; 18(3):771-80.
101. Yu SY, Mizinga KM, Nonavinakere VK, Soliman KF. Decreased endurance to cold water swimming and delayed sexual maturity in the rat following neonatal lead exposure. Toxicol Lett. 1996 Jun; 85(3):135-41.
102. Claye LH, Akunne HC, Davis MD, DeMattos S, Soliman KF. Behavioral and neurochemical changes in the dopaminergic system after repeated cocaine administration. Mol Neurobiol. 1995 Aug-Dec; 11(1-3):55-66.
103. Mizinga KM, Stino FK, Samaan SS, Soliman KF, Kolta MG. Hypothermic effect of ethanol in mice selected for differential sleep-time response to pentobarbital. Pharmacol Biochem Behav. 1995 Jun-Jul; 51(2-3):525-8.
104. Akunne HC, Soliman KF. Serotonin modulation of pain responsiveness in the aged rat. Pharmacol Biochem Behav. 1994 Jun; 48(2):411-6.
105. Stino FK, Soliman KF. Single gene effect on alcohol preference in the Zucker rats. Pharmacol Biochem Behav. 1994 Mar; 47(3):625-31.
106. Williams RL, Soliman KF, Mizinga KM. Circadian variation in tolerance to the hypothermic action of CNS drugs. Pharmacol Biochem Behav. 1993 Oct; 46(2):283-8.
107. Gragg RD, Soliman KF. Biochemical evidence for peripheral neural regulation of adrenocortical regeneration in response to bilateral adrenal enucleation. Life Sci. 1993; 53(3):275-82.
108. Williams R, Ali SF, Scalzo FM, Soliman K, Holson RR. Prenatal haloperidol exposure: effects on brain weights and caudate neurotransmitter levels in rats. Brain Res Bull. 1992 Sep-Oct; 29(3-4):449-58.
109. Wahba ZZ, Soliman KF. Effect of stress on choline acetyltransferase activity of the brain and the adrenal of the rat. Experientia. 1992 Mar 15; 48(3):265-8.
110. Wahba ZZ, Soliman KF, Kolta MG. Effect of diabetes on the cholinergic enzyme activities of the urinary bladder and the seminal vesicles of the rat. Exp Clin Endocrinol. 1992; 99(1):26-30.
111. Goodman CB, Soliman KF. Altered brain cholinergic enzymes activity in the genetically obese rat. Experientia. 1991 Aug 15; 47(8):833-5.
112. Lee JV, Akunne HC, Soliman KF. Involvement of the brain cholinergic system in the rapid development of tolerance to glucose-induced analgesia. Arch Int Pharmacodyn Ther. 1990 Jul-Aug; 306:34-44.
113. Claye LH, Soliman KF. Effect of acute cocaine administration on the cholinergic enzyme levels of specific brain regions in the rat. Pharmacology. 1990; 40(4):218-23.
114. Okonmah AD, Brown JW, Fishman LM, Carballeira A, Soliman KF. Influence of ethanol on fetal brain cholinergic enzyme activities. Pharmacology. 1989; 39(6):367-72.
115. Oriaku ET, Soliman KF. Effect of morphine on the rat gastrointestinal cholinergic enzymes. Arch Int Pharmacodyn Ther. 1989 Jan-Feb; 297:166-77.
116. Brown JW, Okonmah AD, Soliman KF, Carballeira A, Fishman LM. Corticosteroid effects on cholinergic enzymes in ethanol-treated fetal brain cell cultures. Experientia. 1988 Oct 15; 44(10):898-900.
117. Wahba ZZ, Soliman KF. Effect of diabetes on the enzymes of the cholinergic system of the rat brain. Experientia. 1988 Sep 15; 44(9):742-6.
118. Oriaku ET, Soliman KF. Brain cholinergic involvement in the diurnal variations of the rapid development of tolerance to the hypothermic effect of apomorphine. Pharmacology. 1988; 37(1):8-15.
119. Okonmah AD, Brown JW, Owasoyo JO, Soliman KF. Alterations of fetal brain biogenic amine metabolites by maternal ethanol exposure. Gen Pharmacol. 1988; 19(4):589-93.
120. Okonmah AD, Brown JW, Blyden GT, Soliman KF. Prenatal effects of acute harmaline exposure on fetal brain biogenic amine metabolism. Pharmacology. 1988; 37(3):203-8.
121. Akunne HC, Soliman KF. Hyperglycemic suppression of morphine withdrawal signs in the rat. Psychopharmacology (Berl). 1988; 96(1):1-6.
122. Akunne HC, Soliman KF. The role of opioid receptors in diabetes and hyperglycemia-induced changes in pain threshold in the rat. Psychopharmacology (Berl). 1987; 93(2):167-72.
123. Wahba ZZ, Oriaku ET, Soliman KF. Brain cholinergic involvement during the rapid development of tolerance to morphine. Pharmacology. 1987; 34(2-3):66-73.
124. Oriaku ET, Soliman KF. Effect of ethanol on the rat gastrointestinal cholinergic enzymes. Pharmacology. 1987; 35(4):234-40.
125. Soliman KF, Mash DC, Walker CA. The effect of altered 5-hydroxytryptamine levels on beta-endorphin content in rat brain. Proc Soc Exp Biol Med. 1986 Jun; 182(2):187-93.
126. Oriaku ET, Soliman KF. Effect of stress and glucocorticoids on the gastrointestinal cholinergic enzymes. Arch Int Pharmacodyn Ther. 1986 Mar; 280(1):136-44.
127. Okonmah AD, Bradshaw WG, Couceyro P, Soliman KF. The effect of neuroleptic drugs on serum testosterone level in the male rat. Gen Pharmacol. 1986; 17(2):235-8.
128. Kolta MG, Soliman KF, Williams BB. Role of 5-hydroxytryptamine in the regulation of brain neuropeptides in normal and diabetic rat. Horm Res. 1986; 23(2):112-21.
129. Thompson M, Smith M, Gragg R, Soliman KF. Stability of nitroglycerin and dobutamine in 5% dextrose and 0.9% sodium chloride injection. Am J Hosp Pharm. 1985 Feb; 42(2):361-2.
130. Soliman KF, Gabriel NN. Brain cholinergic involvement in the rapid development of tolerance to the hypothermic action of ethanol. Gen Pharmacol. 1985; 16(2):137-40.
131. Soliman KF, Pinkston JN, Owasoyo JO. The role of the adrenal gland in ethanol-induced triglyceride mobilization. Pharmacology. 1984; 29(2):94-8.
132. Soliman KF, Soliman MR, Owasoyo JO, Walker CA. Diurnal variation in the phlogogenic response of rats to inflammatory agents. J Pharm Pharmacol. 1983 Jun; 35(6):388-9.
133. Parker VD, Soliman KF. Brain dopamine variations in gonadotropin-treated immature rat. Experientia. 1983 Feb 15; 39(2):215-7.
134. Gabriel NN, Soliman KF. Effect of stress on the acetylcholinesterase activity of the hypothalamus-pituitary-adrenal axis in the rat. Horm Res. 1983; 17(1):43-8.
135. Soliman KF, Richardson SD. Effect of prenatal exposure to phenobarbital on the development of monoamine oxidase and glucocorticoids. Gen Pharmacol. 1983; 14(3):369-71.
136. Soliman KF, Udoye MO, Iramain CA, Walker CA. Diurnal variation in ornithine decarboxylase activity of different brain regions of the rat. Neurosci Lett. 1982 Dec 13; 33(3):285-8.
137. Walker PY, Soliman KF, Okonmah AD, Owasoyo JO, Walker CA. Circadian variation in the rat plasma level of sodium salicylate administered by two routes. Res Commun Chem Pathol Pharmacol. 1982 Sep; 37(3):483-6.
138. Soliman KF, Kolta MG. In vitro response of the regenerating adrenal gland to epinephrine. Res Commun Chem Pathol Pharmacol. 1981 May; 32(2):373-6.
139. Kolta MG, Soliman KF. Tissue distribution of 3H-corticosterone in response to stress. Endokrinologie. 1981 Apr; 77(2):179-84.
140. Kolta MG, Soliman KF. Effect of peripheral cholinergic activation on the adrenal cortex function. Endocr Res Commun. 1981; 8(4):239-46.
141. Ross FH, Soliman KF, Walker CA. Dexamethasone protection against the acute lethality of ethanol in mice. Experientia. 1980 Apr 15; 36(4):444-5.
142. Okonmah AD, Soliman KF. Pentylenetetrazol effect on adrenocortical maturation in the rat. Horm Res. 1980; 12(2):96-103.
143. Soliman KF, Walker CA. Diurnal rhythm of ethanol metabolism in the rat. Experientia. 1979 Jun 15; 35(6):808-9.
144. Parker VD, Soliman KF, Walker CA. The involvement of serotonin in induced ovulation in the immature rat. Experientia. 1979 May 15; 35(5):692-4.
145. Okonmah AD, Soliman KF. CNS stimulation effect on the sexual maturation of the female rat. Experientia. 1978 Sep 15; 34(9):1238-9.
146. Clausell DE, Soliman KF. Ovarian serotonin content in relation to ovulation. Experientia. 1978 Mar 15; 34(3):410-1.
147. Soliman KF, Walker CA. Dexamethasone suppression of ovulation in PMS-treated immature rats. Experientia. 1977 Mar 15; 33(3):400-1.
148. Soliman KF, Walker CA. Ovarian LDH activity in gonadotropin-treated immature rats. Experientia. 1976 Dec 15; 32(12):1612-3.
149. Soliman KF, Huston TM. Involvement of the adrenal gland in ovulation of the fowl. Poult Sci. 1974 Sep; 53(5):1664-7.

Research Resources icon

Funding Opportunities icon

Browse active NIH & NSF funding opportunities, requests for applications (RFAs), and program announcements (PAs)

Publications Timeline

Top MeSH Keywords

Tree Map of Keyword Semantic Groups (Categories)

Left-click a node to move down the tree, right-click the graph to move back up the tree

Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile:
 
Keyword
Last Name
Institution
 
Keywords
Animals
1-Methyl-4-phenylpyridinium
Microglia
Plant Extracts
Anti-Inflammatory Agents
See all (596) keywords
See all (19) people See all (59) people Search for (2) people
Feedback

RTRN Collaboration and Professional Networking Feedback